FDA Aims to Improve Transparency Website
The U.S. Food and Drug Administration (FDA) has initiated several changes to its transparency website in response to comments from users.
The transparency website for FDA’s Center for Devices and Radiological Health (CDRH) was created as part of an initiative from FDA to become more transparent about industry actions and the products CDRH regulates and the decisions it makes. The website is located here.
CDRH, which asked for feedback from website visitors about the new transparency website, recently addressed the suggestions it received. Among the suggestions were:
- Links to other Useful Databases: CDRH added links to Medical Device Databases and the CDRH Management Directory in the “Resources for You” box on the left side of the CDRH Transparency Homepage.
- RSS Feeds for Databases: CDRH is looking into the feasibility of this with FDA's Office of Information Management.
- More Clinical Trial Data: The plan is to include all PMA clinical trial data.
- Link PMA Clinical Trial Data to Postmarket Information: In the future, PMA Clinical trial data will be included in the Total Product Life Cycle (TPLC) reports.
- Search the TPLC database by brand names or company names: CDRH is accessing the feasibility of adding this feature.
For more information on how to comment on the website, click here.